CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.
Catheter ablation was not the first-line treatment for supraventricular tachycardia (SVT) for most patients referred to a tertiary center, a study shows, with investigators suggesting the procedure is ...
Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
GlobalData on MSN
Stereotaxis secures FDA approval for ablation catheter
The MAGiC catheter is designed to perform minimally invasive cardiac ablation procedures that treat various forms of ...
Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...
Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...
Chloe Dygert revealed that she recently underwent a procedure to treat heart arrhythmia. The U.S. Olympic medalist confirmed doctors carried out a cardiac ablation to treat supraventricular ...
The electrophysiologic mechanism may be due to either enhanced automaticity or triggered activity. In contrast to the paroxysmal variety, the nonparoxysmal type develops gradually and disappears ...
Deltona, Fla.-based Advanced Heart and Vascular Surgery Center, an affiliate of Cardiovascular Centers of America, has become the first ASC in Florida to launch a complete cardiac ablation service ...
We demonstrated a significant rise in CRP at a median of 49 days after AF ablation. Although the subsequent decline in CRP observed at second follow-up (a median of 179 days after ablation) was not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results